Last month, after nearly 5 months of delay, Congress finalized the 2003
federal budget, which included a sizable increase for the National Institutes
of Health (NIH), bringing the agency's budget to $27 billion. This increase
capped 5 years of growth that effectively doubled the budget for NIH, which
is the principal funding source for biomedical research in the United States.
The agency's research portfolio is enormously diverse, ranging from supporting
AIDS research, to research on regenerative medicine, to studies aimed at addressing
terrorist threats to human health.
DeAngelis CD. NIH Director Elias A. Zerhouni, MD, Reflects on Agency's Challenges, Priorities. JAMA. 2003;289(12):1492-1493. doi:10.1001/jama.289.12.1492